atenolol has been researched along with Nerve Degeneration in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asking, B | 2 |
| Emmelin, N | 2 |
| Gjörstrup, P | 2 |
| Pärsson, H | 1 |
2 other studies available for atenolol and Nerve Degeneration
| Article | Year |
|---|---|
Degeneration secretion of amylase from the parotid gland of the rat.
Topics: Amylases; Animals; Atenolol; Dihydroergotamine; Male; Nerve Degeneration; Parotid Gland; Propranolol | 1982 |
Parotid degeneration secretion of amylase in vitro in the rat following sympathectomy.
Topics: Amylases; Animals; Atenolol; Atropine; Culture Techniques; Dihydroergotamine; Ganglia, Sympathetic; | 1982 |